Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$131.63
Price-0.09%
-$0.12
1Y
Price
Market Cap
$229.097b
Large
Price/Earnings 3y Avg5y Avg
16.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+19.8%
EBITDA Margin+16.0%
Net Profit Margin+8.4%
Free Cash Flow MarginRevenue
$43.109b
+2.8%
1y CAGR-0.3%
3y CAGR+0.1%
5y CAGREarnings
$13.979b
+4.3%
1y CAGR+40.4%
3y CAGR+29.8%
5y CAGREPS
$7.99
+4.6%
1y CAGR+40.6%
3y CAGR+30.3%
5y CAGRBook Value
$49.064b
$81.448b
Assets$32.384b
Liabilities$13.242b
DebtDebt to Assets
16.3%
1.2x
Debt to EBITDAFree Cash Flow
$6.657b
+4.8%
1y CAGR-1.6%
3y CAGR-3.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company